Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

HPV16 Related Cancers clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

HPV16 Related Cancers: 1 US clinical trial tracked, none currently recruiting.

HPV16 Related Cancers is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is TScan Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition hpv16-related-cancers

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%HPV16 Related Cancers (this)0%
Open-enrollment share among volume-matched conditions near HPV16 Related Cancers

HPV16 Related Cancers has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for HPV16 Related Cancers on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. HPV16 Related Cancers is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on HPV16 Related Cancers records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Tumor and HLA Profiling Diagnostic test
1 trials

US sites by state

Facility locations filed on HPV16 Related Cancers trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Oklahoma 1 trials
Ohio 1 trials
New York 1 trials
North Carolina 1 trials
Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this HPV16 Related Cancers page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No HPV16 Related Cancers trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • TScan Therapeutics sponsors the most HPV16 Related Cancers trials on record, review their full trial history before evaluating a specific study. See TScan Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HPV16 Related Cancers condition card totals 1 registered trials; most-linked intervention Tumor and HLA Profiling; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.